Question

Is stem cell therapy for ALS (Motor Neurone Disease) covered by insurance?

Do not assume that a trial or insurer pays every ALS cell-therapy cost. Coverage is policy-, country- and protocol-specific. A legitimate sponsored trial may cover the investigational product and protocol-defined procedures, while routine multidisciplinary care, respiratory support, travel or treatment of complications may remain outside the sponsor budget. Obtain written confirmation before enrolment or travel.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The cost picture for ALS (Motor Neurone Disease)

Private investigational ALS cell procedures can involve separate charges for intrathecal administration, neurological and respiratory assessment, imaging, monitoring, travel and treatment of complications. Prices do not indicate regulatory approval or expected benefit, and repeat dosing is not an established standard. Patients should request an itemised written quote and verify sponsor, insurer and patient responsibilities. Multidisciplinary ALS care and approved or guideline-supported treatment must not be delayed.

Am I a candidate? → · ALS (Motor Neurone Disease): full overview → · ALS (Motor Neurone Disease) cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information